Interleukin-13 and -4 induce death of activated microglia

Myung-Soon Yang1, Eun Jung Park, Seonghyang Sohn

  • 1Department of Pharmacology, Ajou University School of Medicine, Suwon, Korea.

Glia
|May 15, 2002
PubMed

Insights

Interleukin-13 (IL-13) selectively induces apoptosis in activated microglia, a key immune cell in brain injury. This finding suggests a novel mechanism for clearing these cells and preventing chronic neuroinflammation.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are immune cells that activate and migrate to sites of brain injury.
  • The mechanisms responsible for the clearance of activated microglia post-injury are not well understood.
  • Persistent microglial activation can contribute to chronic inflammation and tissue damage.

Purpose of the Study:

  • To investigate the mechanisms underlying the disappearance of activated microglia following brain injury.
  • To determine the role of interleukin-13 (IL-13) in regulating activated microglia populations.
  • To explore the potential of IL-13 as a therapeutic target for neuroinflammatory conditions.

Main Methods:

  • In vitro studies using primary microglial cultures.
  • Treatment with microglial activators (lipopolysaccharide, ganglioside, thrombin) and anti-inflammatory cytokines (IL-13, IL-4, TGF-beta).
  • Assessment of cell death using electron microscopy and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining.

Main Results:

  • IL-13 selectively induced cell death in activated microglia, but not in unstimulated cells.
  • Cell death occurred in a time-dependent manner following co-administration of IL-13 with microglial activators.
  • IL-4 mimicked IL-13's effect, while TGF-beta did not.
  • Apoptotic features and microglial phagocytosis of dead cells were observed.

Conclusions:

  • IL-13 and IL-4 induce apoptosis in activated microglia.
  • This cytokine-mediated microglial cell death is a crucial mechanism for preventing chronic neuroinflammation.
  • Targeting this pathway may offer therapeutic benefits for brain injury and related inflammatory diseases.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...